Related Experiment Video

Updated: Aug 21, 2026

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

Anti-BiP antibody levels in juvenile idiopathic arthritis (JIA)

M D Bodman-Smith, M F Fife, H Wythe

    Rheumatology (Oxford, England)
    |September 28, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
    05:45

    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

    Published on: April 5, 2019

    Related Experiment Videos

    Last Updated: Aug 21, 2026

    Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
    10:16

    Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

    Published on: September 15, 2016

    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
    05:45

    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

    Published on: April 5, 2019

    Related Concept Videos

    Antibody Structure and Classes01:25

    Antibody Structure and Classes

    Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
    The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.

    Articles linked to this work by shared authors, journal, and citation graph.

    Efforts towards a precision medicine approach in juvenile idiopathic arthritis.

    Rheumatology (Oxford, England)·2026

    Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective.

    Pediatric rheumatology online journal·2022

    Granulysin: The attractive side of a natural born killer.

    Immunology letters·2019

    Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.

    Neuropathology and applied neurobiology·2018

    Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.

    Neuropathology and applied neurobiology·2018

    Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.

    Pediatric rheumatology online journal·2017

    Identifying biomarkers for methotrexate efficacy in rheumatoid arthritis: a machine learning approach to whole-blood transcriptomic analysis.

    Rheumatology (Oxford, England)·2026

    Use of advanced therapies in systemic lupus erythematosus: a retrospective single centre analysis based on disease phenotypes.

    Rheumatology (Oxford, England)·2026

    Impacts of socioeconomic status on ambulatory care sensitive condition hospitalizations in rheumatoid arthritis.

    Rheumatology (Oxford, England)·2026

    Performance of lupus classification criteria in monogenic lupus: a national multicenter cohort study.

    Rheumatology (Oxford, England)·2026

    Impact of bimekizumab on CANDEN spinal MRI inflammation & structural lesions in radiographic axial spondyloarthritis: 2-year phase 3 results.

    Rheumatology (Oxford, England)·2026

    Efficacy and safety of probiotic supplementation in psoriatic arthritis - a randomized controlled trial.

    Rheumatology (Oxford, England)·2026

    Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance.

    Journal of human immunity·2026

    A Phase 2b Randomized Trial of Belimumab to Reduce Atherogenic Autoantibodies in COPD Patients.

    Chronic obstructive pulmonary diseases (Miami, Fla.)·2026

    Recent Advances in Stimuli Responsive In-Situ Gelling System for the Management of Rheumatoid Arthritis.

    Recent advances in drug delivery and formulation·2026

    Integrated Proteomic and Phosphoproteomic Profiling Reveals Dysregulated Inflammatory Signaling Networks in Rheumatoid Arthritis.

    Omics : a journal of integrative biology·2026

    Mechanisms of neuroimmune crosstalk in vestibular disorders: Linking inflammation with neural circuit dysfunction (Review).

    International journal of molecular medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us